Table 3. Pre- and postoperative increases in FLR volume.
| Variable | Median (range) |
|---|---|
| SLV (urata formula), mL | 1,285.1 (1,190.4–1,400.9) |
| FLR, mL | |
| Preoperative | 306.9 (236.6–467.0) |
| POW1 | 438.5 (328.0–490.0) |
| POW2 | 443.7 (339.6–574.5) |
| POW3 | 539.1 (419.9–806.0) |
| FLR/SLV, % | |
| Preoperative | 24.5 (19.7–36.3) |
| POW1 | 33.4 (27.3–38.1) |
| POW2 | 34.1 (28.2–44.7) |
| POW3 | 42.7 (34.9–62.7) |
| Absolute KGR, mL/day | |
| First week (after ALPPS stage-1) | 15.7 (9.2–30.3) |
| Second week (after ALPPS stage-1) | 2.6 (−10.4–7.1) |
| Third week (after TAE) | 19.5 (3.3–38.6) |
| Relative KGR, % | |
| First week (after ALPPS stage-1) | 4.6 (3.2–10.9) |
| Second week (after ALPPS stage-1) | 0.6 (–2.1–1.8) |
| Third week (after TAE) | 4.1 (0.7–6.7) |
FLR, future liver remnant; SLV, standard liver volume; POW, postoperative week; KGR, kinetic growth rate (daily FLR increase); ALPPS, associating liver partition and portal vein ligation for staged hepatectomy; TAE, transcatheter arterial embolization.